De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Humana Beheer
Beheer criteriumcontroles 2/4
De CEO Humana's is Jim Rechtin, benoemd in Jan2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0% van de aandelen van het bedrijf, ter waarde $ 3.81K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.2 jaar en 4.1 jaar.
Belangrijke informatie
Jim Rechtin
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | less than a year |
Eigendom CEO | 0.00001% |
Management gemiddelde ambtstermijn | 2.2yrs |
Gemiddelde ambtstermijn bestuur | 4.1yrs |
Recente managementupdates
Recent updates
Positive Sentiment Still Eludes Humana Inc. (NYSE:HUM) Following 30% Share Price Slump
Oct 03Wall Street Lunch: Humana Shares Hit Hard
Oct 02Humana's Falling Share Price Gives Investors An Opportunity
Sep 18Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly
Sep 15Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Aug 19Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact
Jul 24Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings
Jul 16Humana: Medicare Advantage Will Never Be As Profitable As It Was
Jun 23Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885
Jun 20Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
Jun 06Humana Is Set Up For Long-Term Success
Jun 05Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885
May 21Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Apr 22Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly
Apr 20Humana: Where To Buy This
Apr 02Humana: This Year's Drop Might Have Created A Buying Opportunity
Mar 19Humana: A Golden Buying Opportunity As Fears Potentially Peaked
Feb 03Humana: The $300 Level Could Get Taken Out In The Near Future
Jan 25Humana: My Oh My, Another Strong Buy
Jan 14Humana: Buy This Powerful Dividend Growth Stock In The New Year
Jan 02Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?
Dec 14Humana: Failed Merger And Other Reasons To Buy
Dec 11Humana: Upgrade To Buy
Oct 06Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did
Sep 27We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease
Aug 25Humana: Mr. Market Got This One Right
Aug 03Humana: Recent Selloff Might Present A Buying Opportunity
Jul 13Humana: Rising Medical Costs Should Be Temporary
Jun 28Humana: Margin Expansion Supported By Growing Memberships
Jun 12Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly
May 26Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 13Humana Q4 2022 Earnings Preview
Jan 31Humana: Destined For A Long-Term Success
Jan 23Humana (NYSE:HUM) Could Easily Take On More Debt
Jan 13Humana receives $70.85B contract from Defense Health Agency
Dec 22Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?
Dec 20Humana: Top-Rated Medicare Advantage Insurer With Room To Grow
Nov 14Humana prices $1.23B debt offering
Nov 08CEO
Jim Rechtin (53 yo)
less than a year
Tenure
Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chief Financial Officer | 3.3yrs | US$4.73m | 0.0072% $ 2.1m | |
Chief Legal Officer | 5.7yrs | US$3.10m | 0.0060% $ 1.7m | |
Strategic Advisor | less than a year | US$16.33m | 0.073% $ 21.2m | |
President of Medicare & Medicaid | 1.7yrs | US$3.11m | 0.0032% $ 913.2k | |
President of CenterWell | 1.6yrs | US$4.58m | 0.00014% $ 40.5k | |
President | less than a year | geen gegevens | 0.000010% $ 2.9k | |
Senior VP | 2.2yrs | geen gegevens | 0.00031% $ 89.6k | |
Senior VP & CTO | less than a year | geen gegevens | geen gegevens | |
Chief Information Officer | 3.8yrs | geen gegevens | 0.010% $ 3.0m | |
Chief Administrative Officer | 5.3yrs | US$3.73m | 0.0061% $ 1.8m | |
Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
Chief Strategy & Corporate Development Officer | 5.8yrs | geen gegevens | 0.0090% $ 2.6m |
2.2yrs
Gemiddelde duur
51.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van HUM wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.2 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | less than a year | geen gegevens | 0.000010% $ 2.9k | |
Independent Chairman of the Board | 21.3yrs | US$601.30k | 0.016% $ 4.7m | |
Independent Director | 5.1yrs | US$346.55k | 0.00049% $ 141.6k | |
Independent Director | 21.1yrs | US$363.55k | 0.017% $ 5.0m | |
Independent Director | 3.7yrs | US$351.59k | 0.0018% $ 514.4k | |
Independent Director | 2.1yrs | US$311.07k | 0.00032% $ 92.5k | |
Independent Director | 4.7yrs | US$364.87k | 0.00037% $ 106.9k | |
Independent Director | 2.6yrs | US$321.52k | 0.00037% $ 106.9k | |
Independent Director | 3.7yrs | US$351.94k | 0.00036% $ 104.0k | |
Independent Director | 4.7yrs | US$326.03k | 0.0010% $ 300.6k | |
Independent Director | 4.1yrs | US$345.03k | 0.00033% $ 95.4k |
4.1yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van HUM wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).